ibandronic acid has been researched along with Anasarca in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fehr, T; Jeker, R; Küchler, L | 1 |
| Friederich, NF; Grize, L; Kraenzlin, C; Kraenzlin, ME; Meier, C; Meier, CR; Wischer, T | 1 |
| Amling, M; Barvencik, F; Luttke, M; Mueller-Wohlfahrt, HW; Simon, MJ; Ueblacker, P | 1 |
| Bartl, C; Bartl, R; Imhoff, A | 1 |
| Dorst, A; Faber, H; Ringe, JD | 1 |
| Bianchi, M; Ferrario, P; Franchi, S; Sacerdote, P; Sotgiu, ML | 1 |
1 trial(s) available for ibandronic acid and Anasarca
| Article | Year |
|---|---|
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Double-Blind Method; Edema; Female; Follow-Up Studies; Humans; Ibandronic Acid; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Osteonecrosis; Pain Measurement; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for ibandronic acid and Anasarca
| Article | Year |
|---|---|
Pain control with ibandronate for bone marrow oedema of the knee.
Topics: Bone Marrow; Bone Marrow Diseases; Diphosphonates; Edema; Humans; Ibandronic Acid; Magnetic Resonance Imaging; Pain; Prospective Studies; Retrospective Studies | 2020 |
Intravenous bisphosphonates and vitamin D in the treatment of bone marrow oedema in professional athletes.
Topics: Adult; Athletes; Bone Density; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Edema; Female; Fractures, Stress; Humans; Ibandronic Acid; Injections, Intravenous; Magnetic Resonance Imaging; Male; Syndrome; Treatment Outcome; Vitamin D | 2014 |
Treatment of bone marrow edema syndrome with intravenous ibandronate.
Topics: Adolescent; Adult; Bone Marrow Diseases; Diphosphonates; Edema; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Knee Joint; Male; Middle Aged; Pilot Projects; Prospective Studies; Syndrome; Talus; Young Adult | 2012 |
Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Bone Marrow; Bone Resorption; Calcium, Dietary; Dietary Supplements; Diphosphonates; Edema; Female; Humans; Ibandronic Acid; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Pain; Pain Measurement; Quality of Life; Syndrome; Treatment Outcome; Vitamin D | 2005 |
Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cytokines; Dinoprostone; Diphosphonates; Drug Evaluation, Preclinical; Edema; Foot; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Ibandronic Acid; Inflammation; Interleukin-1beta; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P; Tumor Necrosis Factor-alpha | 2008 |